Procurement & Supply Chain Management Working Group (PSMWG)
- Reference documents
- Ms Sophie Logez, The Global Fund
Mr Paul Lalvani, New Delhi Empower School of Health
- RBM Secretariat Focal point:
- Dr Jan Van Erps
Tel.: +41 22 791 5867
- Next meeting:
- 10-12 June 2014, Geneva, SWITZERLAND
- ACT/other antimalarials [Co-leads: Jacques Pilloy (OTECI-Artepal), George Jagoe (MMV) and Malcolm Cutler (FSC Development Services Ltd)]
- RDTs [Lead: Jan Jacobs (Institute of Tropical Medicine Antwerp)]
- LLIN and insecticides for IRS [Lead: Abraham Mnzava (WHO/GMP)]
- Global Demand Forecasting [Co-leads: Ali Cameron (UNITAID) and Edwin De Voogd (IDA Foundation)]
- Information and Knowledge (LMIS, mHealth,): [Co-leads: Lisa Hare (JSI) and Mariatou Tala Jallow (Global Fund)]
- PSM Bottleneck Resolution [Lead: Henk den Besten (PFSCM)]
The Procurement and Supply Management Working Group (PSMWG) has been established by the Board in April 2007 to convene and coordinate partners to address Procurement and Supply Chain issues related to malaria control.
The implementation of activities to meet the goals of the RBM partnership requires that a number of challenges related to procurement and supply management be overcome at all levels. These challenges include production scale up in an environment of uncertain demand and funding, inadequate forecasting of core products and supply planning, and weak capacity at country level of supply chain management, including weak logistics information systems. Overcoming these challenges require a coordinated effort by partners and countries which the PSMWG will support.
Functions of the Working Group
The PSMWG will coordinate the implementation support in the following five critical PSM thematic issues/needs. This list may change over time depending on the needs identified by partners.
1. Facilitate PSM Technical Assistance to Countries
PSM bottlenecks have proved to be major implementation constraints in malaria endemic countries.
PSMWG activities for the technical assistance to countries therefore are to:
- with the Subregional RBM Networks identify technical assistance and resources to solve major PSM related constraints when identified.
- maintain rosters of qualified consultants and partner staff that can be drawn from as needed.
- coordinate with partners that have technical assistance resources that can be deployed in these countries.
- establish links with other programs (HIV/AIDS and tuberculosis notably) that have adopted similar approaches and already developed PSM training programs and PSM consultant rosters. Anticipate PSM-related issues that the PSMWG can assist to resolve and include ACT/RDT stock out issues; procurement bottlenecks; inventory management at facility or district level; and distribution plans.
2. Coordinate Global Demand Forecasting and Facilitate Country Quantification of health products
The forecasting and quantification of malaria health products represent an on-going challenge for the malaria community requiring global coordination and harmonization of methodology in order to ensure production planning, avoid shortages, estimate country needs, and conduct gap analysis. PSMWG activities for forecasting and quantification of health products therefore are to:
- take stock of the current status of forecasting for the major health product groups.
- develop harmonized global demand forecast for each core malaria products, including ACTs, LLINs, RDTs and insecticides
- identify partner roles and responsibilities, and best practices in forecasting and quantification methodology.
- propose procedures and mechanisms to improve information sharing in this area.
3. Facilitate resolution of Quality Assurance (QA) /Quality Control (QC) Issues Related to Product Selection and Supply Chain Management
Access to quality assured malaria health products is essential to the fight against malaria, in particular to contain Artemisinin resistance. QA/QC issues related to product availability, selection and in-country supply chain management for all malaria health product categories (insecticides, LLINs, antimalarial medicines, and rapid diagnostic tests) pose serious programmatic challenges in malaria endemic countries. Donors and stakeholders are working closely to facilitate harmonized QA policies and requirements.
PSMWG activities on QA and QC issues therefore are to:
- address the above issues from a product selection, procurement, and supply chain management perspective in line with national policies
- identifying technical guidance, sharing technical resources, and alerting partners, including national regulatory authorities, on relevant QA/QC issues and facilitating coordinated response to QA/QC issues related to malaria health products.
4. Ensure the production, updating and dissemination of Tools, Best Practices, Information
PSMWG activities on tools, best practices and information are to:
- disseminating tools, information and best practices related to PSM matters to partners and countries
- review existing materials, identify gaps in technical knowledge and ensure production, and updating of tools, best practices and information as needed.
- look towards partnership and information sharing with other disease categories such as HIV/AIDS and TB when appropriate, recognizing that in-country supply chains are integrated across health product categories,
5. Advocate for, and facilitate resource mobilization for global and in-country PSM operations
PSMWG activities on advocacy for resource mobilization for in-country PSM activities and pharmaceutical supply systems strengthening are to:
- collect information on resources dedicated to PSM activities and capacity building
- evaluate gaps and develop advocacy for proper resourcing of in-country management and distribution systems.
- coordination of PSM messaging and funding needs with other RBM Working Groups such as the Harmonization Working Group
- in conducting these activities, appropriate consideration to confidentiality will be given as needed.
For further information, please refer to the PSMWG Revised Terms of Reference adopted in January 2014 following the 25th RBM Partnership Board meeting.